AstraZeneca undershoots expectations

April 26th, 2008 by

admin

AstraZeneca, the Anglo-Swedish pharmaceuticals company, saw pre-tax profits start 5 per coin to $2.1bn in the prototypal quarter

Posted in Pharmaceuticals |

Related posts

Comments are closed.

Recent Posts

Low-grade gliomas in adults
Anaplastic oligodendroglioma
New fifth edition serum-free light chain analysis
Final data from phase 1 investigator-sponsored trial of oncophage® cancer vaccine in glioma presented at the society for neuro-oncology’s annual meeting
Human bre1 is an e3 ubiquitin ligase for ebp1 tumor suppressor.
A pilot study of human interferon {beta} gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes
Bax and bid act in synergy to bring about t11ts-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation
Free teleconference on latest glioma treatments: a program for patients and families presented by: dr. howard fine
Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor
In vitro antitumor mechanisms of various scutellaria extracts and constituent flavonoids

Categories

Archives:

Search: